Clinical Trials Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLCAugust 8, 2026
Clinical Trials Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid CancerAugust 7, 2026